Abstract
Objective
We report two Hungarian patients with familial hypocalciuric hypercalcemia (FHH) caused
by a mutation of the calcium-sensing receptor (CaSR) at codon 55. The proband and
her father were heterozygous for this mutation.
Design
We performed detailed clinical and laboratory assessments of this family to characterize
the effects of CaSR mutation on several endocrine organs expressing CaSR.
Results
Interestingly, we could not detect any failure in the function of any tissues we examined,
except in serum calcium levels.
Conclusions
To our knowledge, this has been the first report from Eastern and Central Europe showing
P55 L mutation of the CaSR, as well as the first publication discussing the effect
of this mutation on several endocrine systems containing CASR.
Key words
Calcium-sensing receptor - familial hypocalciuric hypercalcemia - calcium metabolism
References
1
Aida K, Koishi S, Inoue M, Nakazato M, Tawata M, Onaya T.
Familial hypocalciuric hypercalcaemia associated with mutation in the human Ca2+ -sensing receptor gene.
J Clin Endocrinol Metab.
1995;
80
2594-2598
2
Bai M, Quinn S, Trivedi S, Kifor O, Pearce S HS, Pollak M R, Krapcho K, Hebert S C,
Brown E M.
Expression and characterization of inactivating and activating mutations in the human
Ca2+
0 -sensing receptor.
J Biol Chem.
1996;
271
19537-19545
3
Boonstra C E, Jackson C E.
Serum calcium survey for hyperparathyroidism.
Am J Clin Pathol.
1971;
55
523-526
4
Brown E M, Pollak M.
The extracellular calcium-sensing receptor: Its role in health and disease.
Ann Rev Med.
1998;
49
15-29
5
Brown E M, Hebert S C.
Calcium-receptor-regulated parathyroid and renal function.
Bone.
1997;
20
303-309
6
Cetani F, Pardi E, Borsari S, Tonacchera M, Morabito E, Pinchera A, Marcocci C.
Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function
mutations in the calcium-sensing receptor (CaR) gene: functional characterization
of a novel CaR missense mutation.
Clin Endocrinol.
2003;
58
199-206
7
Chikatsu N, Fukumoto S, Suzawa M, Tanaka Y, Takeucji Y, Takeda S, Tamura Y, Matsumoto T,
Fujita T.
An adult patient with severe hypercalcaemia and hypocalciuria due to a novel homozygous
inactivating mutation of calcium-sensing receptor.
Clin Endocrinol.
1999;
50
537-543
8
Fukumoto S, Chikatsu N, Okazaki R, Takeuchi Y, Tamura Y, Murakami T, Obara T, Fujita T.
Inactivating mutations of calcium-sensing receptor results in parathyroid lipohyperplasia.
Diagn Mol Pathol.
2001;
10
242-247
9
Health 3rd H, Odelberg S, Jackson C E, Teh B T, Hayward N, Larsson C, Buist N R, Krapcho K J,
Hung B C, Capuano I V, Garrett J E, Leppert M F.
Clustered inactivating mutations and benign polymorphisms of the calcium receptor
gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains.
J Clin Endocrinol Metabol.
1996;
81
1312-1317
10
Hinnie J, Bell E, McKillop E, Gallacher S.
The prevalence of familial hypocalciuric hypercalcaemia.
Calcif Tissue International.
2001;
68
216-218
11
Jap T S, Wu Y C, Jenq S F, Won G S.
A novel mutation in the calcium-sensing receptor gene in a Chinese subject with persistent
hypercalcaemia and hypocalciuria.
J Clin Endocrinol Metab.
2001;
86
13-15
12
Kanazawa H, Tanaka H, Kodama S, Moriwake A, Kobayashi M, Seino Y.
The effect of calcium-sensing receptor gene polymorphism on serum calcium levels:
a familial hypocalciuric hypercalcaemia family without mutation in the calcium-sensing
receptor gene.
Endocrine J.
2000;
47
29-35
13
Kobayashi M, Tanaka H, Tsuzuki K, Tsuyuki M, Igaki H, Ichinose Y, Aya K, Nishioka N,
Seino Y.
Two novel missence mutations in calcium-sensing receptor gene associated with neonatal
severe hyperparathyroidism.
J Clin Endocrinol Metab.
1997;
82
2716-2719
14
Koishi S, Aida K, Tawata M, Onaya T.
Polymorphism of the human Ca2+ -sensing receptor gene in Japanese individuals: no relation to non-insulin dependent
diabetes mellitus.
Horm Metab Res.
1996;
28
541-544
15
Law W M, Heath 3rd H.
Familial benign hypercalcaemia (hypocalciuric hypercalcaemia).
Ann Intern Med.
1985;
102
511-519
16
Levy J.
Abnormal cell calcium homeostasis in type 2 diabetes mellitus: a new look on old disease.
Endocrine.
1999;
10
1-6
17
Paterson C R, Gunn A.
Familial benign hypercalcaemia.
Lancet.
1981;
2
61-63
18
Pearce S HS, Trump D, Wooding C, Besser G M, Chew S L, Grant D B, Heath D A, Hughes I A,
Paterson C R, Whyte M P, Thakker R V.
Calcium-sensing receptor mutations in familial benign hypercalcaemia and neonatal
hyperparathyroidism.
J Clin Invest.
1995;
96
2683-2692
19
Pearce S HS, Brown E M.
Disorders of calcium ion sensing.
J Clin Endocrinol Metab.
1996;
81
2030-2035
20
Pollak M R, Brown E M, Chou Y-HW, Hebert S, Marx S J, Steinmann B, Levi T, Seidman C,
Seidman J G.
Mutations in the human Ca2+ -sensing receptor gene cause familial hypocalciuric hypercalcaemia and neonatal severe
hyperparathyroidism.
Cell.
1993;
75
1297-1303
21
Romoli R, Lania A, Mantovani G, Corbeta S, Persani L, Spada A.
Expression of calcium-sensing receptor and characterization of intracellular signaling
in human pituitary adenomas.
J Clin Endocrinol Metab.
1999;
84
2848-2853
M. D. PhD Gábor Speer
1st Department of Medicine Faculty of Medicine · Semmelweis University Budapest
Korányi 2/a
Budapest 1083
Hungary
Phone: + 3612100278/ext. 1566
Fax: + 36 12 10 48 74
Email: speerga@bel1.sote.hu